ArticleMolecular psychiatry2022

Brain-penetrant calcium channel blockers are associated with a reduced incidence of neuropsychiatric disorders.

Lucy Colbourne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.